After crafting an indications table for the different GLP1-RA products last month, I noted it was also time to update approximate equivalent doses based on data and clinical experience with tirzepatide, which was new to the market the first time we created this chart.
The ultimate guide for GLP-1 agonist dosing. Includes titration schedules, conversion estimates between semaglutide, tirzepatide, liraglutide, dulaglutide.
Convert your prescribed GLP-1 medication dose from mg to units for compounded semaglutide and tirzepatide vials. Enter your vial concentration and prescribed dose to see the exact units to draw on a U-100 insulin syringe.
Furthermore, visual representations like the one above help us fully grasp the concept of Glp 1 Equivalency Chart.
sist with the conversion of GLP-1 RA agents. Please see the FDA Drug Shortages website for up-to-da information on specific dose availability. Assessment of equivalent dose is based on head-to-head clinical trials
Chart: Drugs for Type 2 Diabetes December 2024 Chart: Comparison of GLP-1 and GIP/GLP-1 Receptor Agonists August 2024 Chart: Guide for Helping Patients Afford Their Medications March 2024 Article: Help Navigate Common Hurdles With GLP-1 Agonists February 2024 Article: Know When to Use a GLP-1 Agonist or SGLT2i First-Line February 2023
